1.C.12.1.16 Vaginolysin (VLY) of 516 aas and 1 N-terminal TMS. It plays a role in bacterial vaginosis (BV), a vaginal anaerobic dysbiosis that affects
women of reproductive age worldwide. BV is microbiologically
characterized by the depletion of vaginal lactobacilli and the
overgrowth of anaerobic bacterial species. Gardnerella spp. have a pivotal role among BV-associated bacteria in the initiation and development of BV (Pleckaityte 2019). Inerolysin (INY) (TC# 1.C.12.1.17)-induced damage of artificial membranes is directly dependent on
the cholesterol concentration in the bilayer, whereas VLY-induced damage
occurs only with high levels of membrane cholesterol (>40 mol%) (Ragaliauskas et al. 2019). VLY
primarily forms membrane-embedded complete rings in the synthetic
bilayer, whereas INY forms arciform structures with smaller pore sizes.
VLY activity is high at elevated pH, which is characteristic of BV,
whereas INY activity is high at more acidic pH, which is characteristic of a
healthy vagina (Pleckaityte 2019).
|
Accession Number: | ACD39461.1 |
Protein Name: | ACD39461.1 vaginolysin [Gardnerella vaginalis] |
Length: | 517 |
Molecular Weight: | |
Species: | Gardnerella vaginalis [2702] |
Number of TMSs: | 1 |
Substrate |
|
---|
1: MKSTKFYRNA AMLLLAGATI VPQCLAAPAM AAPSAKDSEP ATSCAAKKDS LNNYLWDLQY
61: DKTNILARHG ETIENKFSSD SFNKNGEFVV VEHQKKNITN TTSNLSVTSA NDDRVYPGAL
121: FRADKNLMDN MPSLISANRA PITLSVDLPG FHGGESAVTV QRPTKSSVTS AVNGLVSKWN
181: AQYGASHHVA ARMQYDSASA QSMNQLKAKF GADFAKIGVP LKIDFDAVHK GEKQTQIVNF
241: KQTYYTVSVD APDSPADFFA PCTTPDSLKN RGVDNKRPPV YVSNVAYGRS MYVKFDTTSK
301: STDFQAAVEA AIKGVEIKPN TEFHRILQNT SVTAVILGGS ANGAAKVITG NIDTLKALIQ
361: EGANLSTSSP AVPIAYTTSF VKDNEVATLQ SNSDYIETKV SSYRNGYLTL DHRGAYVARY
421: YIYWDEYGTE IDGTPYVRSR AWEGNGKYRT AHFNTTIQFK GNVRNLRIKL VEKTGLVWEP
481: WRTVYDRSDL PLVHQRTISN WGTTLWPRVA ETVKND